{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:09:48Z","timestamp":1778630988596,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000354","name":"Food Standards Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010882","name":"Australasian Society of Clinical Immunology and Allergy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaip.2022.10.038","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:59:19Z","timestamp":1667962759000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Food Allergy and Eosinophilic Gastrointestinal Diseases\u2014The Next 10 Years"],"prefix":"10.1016","volume":"11","author":[{"given":"Paul J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi L.K.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.10.038_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000358616","article-title":"History of food allergy","volume":"100","author":"W\u00fcthrich","year":"2014","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib2","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(14)62327-8","article-title":"Another person's poison","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(00)67313-0","article-title":"A\u00a0case of egg poisoning","volume":"171","author":"Schofield","year":"1908","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib4","first-page":"219","article-title":"A\u00a0case of food allergy: idiosyncrasy to eggs, almonds and oats, due to anaphylaxis","volume":"29","author":"Schloss","year":"1912","journal-title":"Arch Paediat"},{"key":"10.1016\/j.jaip.2022.10.038_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0016-5085(78)90710-2","article-title":"Eosinophilic esophagitis in a patient with vigorous achalasia","volume":"74","author":"Landres","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.10.038_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2022.05.012","article-title":"Eosinophilic gastrointestinal diseases make a name for themselves: a new consensus statement with updated nomenclature","volume":"150","author":"Wright","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.10.038_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.038_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jama.2022.6263","article-title":"Can peanut allergy prevention be translated to the pediatric population?","volume":"328","author":"Dantzer","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.10.038_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaci.2019.06.045","article-title":"Enquiring About Tolerance (EAT) study team. Efficacy of the Enquiring About Tolerance (EAT) study among infants at high risk of developing food allergy","volume":"144","author":"Perkin","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib11","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/S0140-6736(22)00687-0","article-title":"Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial","volume":"399","author":"Skjerven","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/pai.13273","article-title":"Preventing food allergy in infancy and childhood: systematic review of randomised controlled trials","volume":"31","author":"de Silva","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(22)00788-7","article-title":"Early introduction of allergenic food for all infants","volume":"399","author":"Perkin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jaci.2015.11.029","article-title":"Calculating the effect of population-level implementation of the Learning Early About Peanut Allergy (LEAP) protocol to prevent peanut allergy","volume":"137","author":"O'Connor","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2022.9224","article-title":"Association between earlier introduction of peanut and prevalence of peanut allergy in infants in Australia","volume":"328","author":"Soriano","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.10.038_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2021.12.795","article-title":"Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines","volume":"150","author":"Mullins","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0140-6736(19)32984-8","article-title":"Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial","volume":"395","author":"Chalmers","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cea.14085","article-title":"Individual participant data meta-analysis versus aggregate data meta-analysis: a case study in eczema and food allergy prevention","volume":"52","author":"Van Vogt","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib19","doi-asserted-by":"crossref","unstructured":"Chaoimh CN, Lad D, Nico C, Puppels GJ, Wong XFCC, Common JE, et\u00a0al. Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants-The STOP-AD randomised controlled trial. Allergy. Published online August 23, 2022. https:\/\/doi.org\/10.1111\/all.15491","DOI":"10.1111\/all.15491"},{"key":"10.1016\/j.jaip.2022.10.038_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056925","article-title":"PrEggNut study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to four months' lactation on infant IgE-mediated egg and peanut allergy outcomes","volume":"12","author":"Palmer","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2022.10.038_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13845","article-title":"Maternal peanut and egg consumption during breastfeeding randomized pilot trial","volume":"33","author":"Palmer","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2011.01.039","article-title":"Prevalence of challenge-proven IgE-mediated food allergy using population- based sampling and predetermined challenge criteria in infants","volume":"127","author":"Osborne","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaci.2009.10.008","article-title":"Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics","volume":"125","author":"Nicolaou","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jaci.2012.01.056","article-title":"Increasing the accuracy of peanut allergy diagnosis by using Ara h 2","volume":"129","author":"Dang","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaip.2020.08.060","article-title":"Added diagnostic value of peanut component testing: a cross-sectional study in Australian children","volume":"9","author":"Kaur","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2014.04.039","article-title":"Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children","volume":"134","author":"Santos","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2018.01.043","article-title":"Mast cell activation test in the diagnosis of allergic disease and anaphylaxis","volume":"142","author":"Bahri","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib28","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/all.14747","article-title":"Basophil activation test: mechanisms and considerations for use in clinical trials and clinical practice","volume":"76","author":"Santos","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib29","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/all.12442","article-title":"The impact of oral food challenge tests on food allergy health-related quality of life","volume":"69","author":"Soller","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/archdischild-2020-319906","article-title":"Self-administration of adrenaline for anaphylaxis during in-hospital food challenges improves health-related quality of life","volume":"106","author":"Burrell","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaip.2022.10.038_bib31","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/all.15477","article-title":"Predicting probability of tolerating discrete amounts of peanut protein in allergic children using epitope-specific IgE antibody profiling","volume":"77","author":"Suprun","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib32","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/all.15318","article-title":"Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis","volume":"77","author":"Turner","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2021.07.035","article-title":"Anaphylaxis knowledge gaps and future research priorities: a consensus report","volume":"149","author":"Dribin","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jaci.2017.01.030","article-title":"Peanut Allergen Threshold Study (PATS): novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy","volume":"139","author":"Hourihane","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib35","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/all.15312","article-title":"Single low-dose exposure to cow's milk at diagnosis accelerates cow's milk allergic infants' progress on a milk ladder programme","volume":"77","author":"d'Art","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib36","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jaip.2019.12.028","article-title":"Anxiety associated with food allergy in adults and adolescents: an analysis of data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010","volume":"8","author":"Dantzer","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11882-016-0614-9","article-title":"Quality of life among food allergic patients and their caregivers","volume":"16","author":"Warren","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.10.038_bib39","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaip.2021.12.022","article-title":"Real-world adoption of FDA-approved peanut oral immunotherapy with Palforzia","volume":"10","author":"Patrawala","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/pai.12510","article-title":"Improving the safety of oral immunotherapy for food allergy","volume":"27","author":"Vazquez-Ortiz","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13223-022-00696-w","article-title":"Patient selection for milk and egg ladders using a food ladder safety checklist","volume":"18","author":"Chua","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib42","doi-asserted-by":"crossref","first-page":"n251","DOI":"10.1136\/bmj.n251","article-title":"Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018","volume":"372","author":"Baseggio Conrado","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2022.10.038_bib43","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/pai.12148","article-title":"Persistent allergy to cow's milk: of greater a clinical concern than other food allergies","volume":"24","author":"Turner","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaip.2021.05.021","article-title":"Managing food allergy when the patient is not highly allergic","volume":"10","author":"Sicherer","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2352-4642(22)00006-2","article-title":"Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial","volume":"6","author":"Loke","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2022.10.038_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fsufs.2021.630393","article-title":"Recent developments in smart food packaging focused on biobased and biodegradable polymers","volume":"5","author":"Salgado","year":"2021","journal-title":"Front Sustain Food Syst"},{"key":"10.1016\/j.jaip.2022.10.038_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2022.08.008","article-title":"Treatment for food allergy: current status and unmet needs","volume":"151","author":"Dantzer","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol. Published online August"},{"key":"10.1016\/j.jaip.2022.10.038_bib49","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11882-019-0839-5","article-title":"Next-generation approaches for the treatment of food allergy","volume":"19","author":"Dantzer","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.10.038_bib51","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/cea.13897","article-title":"The use of biologics in food allergy","volume":"51","author":"Fiocchi","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib52","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","article-title":"Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy","volume":"130","author":"Savage","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib53","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jaip.2019.01.023","article-title":"Impact of omalizumab on food allergy in patients treated for asthma: a real-life study","volume":"7","author":"Fiocchi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000744","article-title":"Omalizumab as monotherapy for food allergy","volume":"21","author":"Arasi","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/ACI.0000000000000736","article-title":"Omalizumab as an adjuvant in food allergen immunotherapy","volume":"21","author":"Dantzer","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13223-017-0223-8","article-title":"Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab","volume":"13","author":"Andorf","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib57","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/all.15217","article-title":"Phase 2, randomized multi oral immunotherapy with omalizumab 'real life' study","volume":"77","author":"Sindher","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib58","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S2468-1253(17)30392-8","article-title":"Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial","volume":"3","author":"Andorf","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.10.038_bib60","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacig.2022.05.006","article-title":"Protocol design and synopsis: omalizumab as monotherapy and as adjunct therapy to multiallergen OIT in children and adults with food allergy (OUtMATCH)","volume":"1","author":"Wood","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Global"},{"key":"10.1016\/j.jaip.2022.10.038_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131347","article-title":"Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy","volume":"4","author":"Chinthrajah","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaip.2022.10.038_bib64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2018.10.051","article-title":"RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis","volume":"156","author":"Hirano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.10.038_bib65","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cgh.2020.03.036","article-title":"Long-term efficacy and tolerability of RPC4046 in an open-label extension trial of patients with eosinophilic esophagitis","volume":"19","author":"Dellon","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2022.10.038_bib66","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","article-title":"An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis","volume":"141","author":"Assa'ad","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2022.10.038_bib67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaip.2022.10.038_bib68","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","article-title":"Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial","volume":"129","author":"Spergel","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100676","article-title":"Current and emerging biologic therapies targeting eosinophilic disorders","volume":"15","author":"Pitlick","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2022.10.038_bib70","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaip.2022.02.037","article-title":"Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic gastrointestinal disease","volume":"10","author":"Kuang","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib71","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.038_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.941020","article-title":"Measuring the impact of food immunotherapy on health-related quality of life in clinical trials","volume":"3","author":"Lloyd","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib73","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/all.15211","article-title":"Allergen immunotherapy and\/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"77","author":"Silva","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib74","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaci.2018.09.035","article-title":"Evaluating primary end points in peanut immunotherapy clinical trials","volume":"143","author":"Rodr\u00edguez Del R\u00edo","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11882-016-0602-0","article-title":"The heterogeneity of oral immunotherapy clinical trials: implications and future directions","volume":"16","author":"Yee","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.10.038_bib76","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.10.038_bib77","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jama.2019.1113","article-title":"Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial","volume":"321","author":"Fleischer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.10.038_bib78","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/all.12405","article-title":"EAACI food allergy and anaphylaxis guidelines. Food allergy health-related quality of life measures","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib79","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ACI.0000000000000271","article-title":"Food allergy quality of life and living with food allergy","volume":"16","author":"Greenhawt","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib80","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.jaip.2021.05.020","article-title":"Improvement in health-related quality of life in food-allergic patients: a meta-analysis","volume":"9","author":"Cao","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.10.038_bib81","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.anai.2020.06.023","article-title":"Outcomes for clinical trials of food allergy treatments","volume":"125","author":"Sim","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib82","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.iac.2019.09.005","article-title":"Peanut oral immunotherapy: state of the art","volume":"40","author":"Tang","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.10.038_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2017.11.004","article-title":"Treatment for food allergy","volume":"141","author":"Burks","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11882-019-0862-6","article-title":"GRADE-ing the benefit\/risk equation in food immunotherapy","volume":"19","author":"Duca","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.10.038_bib85","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib86","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.10.038_bib87","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib88","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jaip.2020.12.029","article-title":"Continuous and daily oral immunotherapy for peanut allergy: results from a 2-year open-label follow-on study","volume":"9","author":"Vickery","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"suppl 2","key":"10.1016\/j.jaip.2022.10.038_bib89","doi-asserted-by":"crossref","first-page":"AB139","DOI":"10.1016\/j.jaci.2021.12.472","article-title":"Longer duration of peanut oral immunotherapy at a reduced dosing frequency increases the rate of sustained unresponsiveness without reducing clinical efficacy","volume":"149","author":"Turner","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib90","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10875-011-9605-8","article-title":"In\u00a0vitro desensitization of human skin mast cells","volume":"32","author":"Zhao","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.10.038_bib91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/cea.14137","article-title":"Probiotic peanut oral immunotherapy is associated with long-term persistence of 8-week sustained unresponsiveness and long-lasting quality-of-life improvement","volume":"52","author":"Loke","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.10.038_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2352-4642(17)30041-X","article-title":"Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hsiao","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2022.10.038_bib93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822011412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:35:22Z","timestamp":1761975322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822011412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213219822011412"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.10.038","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food Allergy and Eosinophilic Gastrointestinal Diseases\u2014The Next 10 Years","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}